Toxicology, ADME & Early Drug Development Plan

Toxicology, ADME & Early Drug Development Plan is a conference dedicated to building an integrated safety testing strategy based on adme and toxicology.

Topics

• Lead Optimization to application for First in Man (FIM) clinical trials
• Absorption, Distribution, Metabolism and Excretion (ADME) and Toxicology studies from
• First human dose prediction
• Synergies between ADME and Toxicology studies during early drug development
• Early Drug Development Plan – studies and critical milestones
• Quality standards during Early Drug Development
• Key regulatory documents & submission of ADME and Toxicology data

Who should Attend

From Pharmaceutical, Biotech, Biologics, Drug Development, Pharmacology, and Drug Manufacturing with job titles such as:

• Research Scientist / Pre-clinical Scientists
• Project Managers, Project Coordinators
• Toxicologists
• Drug development program managers
• CMC/Manufacturing Scientists and Managers
• Outsourcing managers
• Regulatory Affairs Managers
• Business Managers
• Outsourcing strategyCRO selection Study management and monitoring
• Quality Assurance Professionals